Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Diana Z Osmanova"'
Autor:
Diana Z. Osmanova, Maxim B. Freidin, Olga Yu. Fedorenko, Ivan V. Pozhidaev, Anastasiia S. Boiko, Natalia M. Vyalova, Vladimir V. Tiguntsev, Elena G. Kornetova, Anton J. M. Loonen, Arkadiy V. Semke, Bob Wilffert, Nikolay A. Bokhan, Svetlana A. Ivanova
Publikováno v:
BMC Medical Genetics, Vol 20, Iss S1, Pp 35-44 (2019)
Abstract Background Hyperprolactinemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 receptors (DRD2s) on the membranes of lactotroph cells within the pituitary gland. Certain antipsychotic d
Externí odkaz:
https://doaj.org/article/d99fb35098324075997db59f81e60a4e
Autor:
Svetlana A. Ivanova, Valentina M. Alifirova, Irina A. Zhukova, Vladimir V. Tiguntsev, Ivan V. Pozhidaev, Diana Z. Osmanova, Olga Yu. Fedorenko, Maxim B. Freydin, Yulia S. Mironova, Natalia G. Zhukova, Nikolay A. Bokhan, Anton J.M. Loonen
Publikováno v:
Бюллетень сибирской медицины, Vol 16, Iss 3, Pp 70-78 (2017)
Parkinson’s disease (PD) is one of the most serious and widespread neurodegenerative disorders. Genetic susceptibility plays a significant role in the development of PD.The aim of our study was to investigate associations between single nucleotide
Externí odkaz:
https://doaj.org/article/a3d567e06fbd46ed91b7ceb3a80df791
Autor:
Svetlana A. Ivanova, Valentina M. Alifirova, Ivan V. Pozhidaev, Maxim B. Freidin, Irina A. Zhukova, Diana Z. Osmanova, Natalia G. Zhukova, Yulia A. Mironova, Vladimir V. Tiguntsev, Olga Yu. Fedorenko, Nikolay A. Bokhan, Bob Wilffert, Anton J.M. Loonen
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 21, Iss 1 (2018)
Purpose. Parkinson's disease (PD), a common neurodegenerative disorder, is usually treated with Levodopa (L-DOPA). The use of this drug, however, is severely limited by the development of side effects of the motor system: Levodopa-induced dyskinesia
Externí odkaz:
https://doaj.org/article/046522b813944757920a574425e7c34e
Autor:
Olga Yu Fedorenko, Diana Z Osmanova, Nikolay A. Bokhan, Anton J. M. Loonen, Maxim B. Freidin, Anastasiia S Boiko, A. Semke, Ivan V Pozhidaev, Bob Wilffert, Svetlana A. Ivanova
Publikováno v:
The World Journal of Biological Psychiatry, 21(1), 72-77. Taylor & Francis Ltd
Objectives: Acetylcholine M (muscarinic) receptors are possibly involved in tardive dyskinesia (TD). The authors tried to verify this hypothesis by testing for possible associations between two muscarinic receptor genes (CHRM1 and CHRM2) polymorphism
Autor:
Nikolay A. Bokhan, Natalya M. Vyalova, Innokentiy S. Losenkov, Fokko J. Bosker, Ekaterina V Mikhalitskaya, Bob Wilffert, G. G. Simutkin, Anton J. M. Loonen, Svetlana A. Ivanova, Diana Z Osmanova, L. A. Levchuk, Taichi Ochi
Publikováno v:
Journal of Affective Disorders, 259, 432-439. ELSEVIER SCIENCE BV
Background: Brain-derived neurotrophic factor (BDNF) is associated with response to antidepressant drugs in mood and anxiety disorders. Prolactin (PRL) is a pituitary hormone with behavioural effects, acting as a neurotrophic factor within the brain
Autor:
Diana Z Osmanova, M. Titova, Svetlana A. Ivanova, Valentina M. Alifirova, Semkina A. AnastasiIa, Ekaterina S. Koroleva
Publikováno v:
Annals of the Russian academy of medical sciences. 74:14-19
Background : Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that affects people of working age and ultimately leads to disability. This disease is of polygenic origin. The role of factors related to the pathogenesis of
Autor:
O. Izhboldina, Irina Zhukova, N. G. Zhukova, Yu. S. Mironova, A. V. Latypova, Anastasiia S Boiko, Svetlana A. Ivanova, Diana Z Osmanova, Valentina M. Alifirova
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 10, Iss 2, Pp 27-32 (2018)
Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated with multi-neurotransmitter dysfunction, so it is important to search for genetic risk factors that determine different clinical types of this disease. Obje
Autor:
Diana Z Osmanova, Irina Zhukova, Yulia A Mironova, Bob Wilffert, Natalia G. Zhukova, Nikolay A. Bokhan, Vladimir V Tiguntsev, Anton J. M. Loonen, Svetlana A. Ivanova, Olga Yu Fedorenko, Maxim B. Freidin, Ivan V Pozhidaev, Valentina M. Alifirova
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 21, Iss 1 (2018)
Journal of pharmacy and pharmaceutical sciences, 21(1), 340-346
Journal of pharmacy and pharmaceutical sciences, 21(1), 340-346
PURPOSE: Parkinson's disease (PD), a common neurodegenerative disorder, is usually treated with Levodopa (L-DOPA). The use of this drug, however, is severely limited by the development of side effects of the motor system: Levodopa-induced dyskinesia
Autor:
Diana Z Osmanova, Valentina M. Alifirova, Vladimir V Tiguntsev, Anton J. M. Loonen, Olga Yu Fedorenko, Ivan V Pozhidaev, Nikolay A. Bokhan, Maxim B. Freydin, Irina Zhukova, Natalia G. Zhukova, Yulia S. Mironova, Svetlana A. Ivanova
Publikováno v:
Byulleten sibirskoy meditsiny, 16(3), 70-78. SIBERIAN STATE MEDICAL UNIV
Bûlleten' Sibirskoj Mediciny, Vol 16, Iss 3, Pp 70-78 (2017)
Bûlleten' Sibirskoj Mediciny, Vol 16, Iss 3, Pp 70-78 (2017)
Parkinson's disease (PD) is one of the most serious and widespread neurodegenerative disorders. Genetic susceptibility plays a significant role in the development of PD.The aim of our study was to investigate associations between single nucleotide po
Autor:
Diana Z Osmanova, L. A. Levchuk, N. Vyalova, Innokentiy S. Losenkov, Nikolay A. Bokhan, Taichi Ochi, Fokko J. Bosker, Ekaterina V Mikhalitskaya, S. Ivanova, Bob Wilffert, G. G. Simutkin, Antonius Loonen
Publikováno v:
European Neuropsychopharmacology, 29(Suppl. 6), S355-S356. ELSEVIER SCIENCE BV